Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Selling, general, & admin. expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. Bio Medica Laboratories's selling, general, & admin. expense for the
six
months ended in Mar. 2025 was ₹1.9 Mil.
Bio Medica Laboratories does not have enough years/quarters to calculate its selling, general, & admin. expense for the trailing twelve months (TTM) ended in Mar. 2025.
Bio Medica Laboratories (NSE:BMLL) Selling, General, & Admin. Expense Explanation
An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.
Warren Buffett likes companies with consistent SGA as the percentage of gross profit.
Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.
If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.
Bio Medica Laboratories Selling, General, & Admin. Expense Related Terms
Bio Medica Laboratories Selling, General, & Admin. Expense Historical Data
* Premium members only.
The historical data trend for Bio Medica Laboratories's Selling, General, & Admin. Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bio Medica Laboratories Selling, General, & Admin. Expense Chart
Bio Medica Laboratories Annual Data
Trend
Mar23
Mar24
Mar25
Selling, General, & Admin. Expense
0.43
0.50
1.92
Bio Medica Laboratories Semi-Annual Data
Mar23
Mar24
Mar25
Selling, General, & Admin. Expense
0.43
0.50
1.92
NSE:BMLL vs ISRG, BDX, MDLN: Selling, General, & Admin. Expense Comparison
For the Medical Instruments & Supplies subindustry, Bio Medica Laboratories's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bio Medica Laboratories Selling, General, & Admin. Expense vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bio Medica Laboratories's Selling, General, & Admin. Expense distribution charts can be found below:
* The bar in red indicates where Bio Medica Laboratories's Selling, General, & Admin. Expense falls into.
Bio Medica Laboratories Selling, General, & Admin. Expense Calculation
Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.
What does a Selling, General, & Admin. Expense of ₹ Mil mean?
Bio Medica Laboratories (NSE:BMLL) has a Selling, General, & Admin. Expense of ₹ Mil as of Mar. 2025. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on Bio Medica Laboratories and its competitors.
Is Bio Medica Laboratories' Selling, General, & Admin. Expense too high?
Bio Medica Laboratories' current Selling, General, & Admin. Expense is ₹ Mil. Overall, Bio Medica Laboratories has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Bio Medica Laboratories' Selling, General, & Admin. Expense compare to ISRG and BDX?
Bio Medica Laboratories' Selling, General, & Admin. Expense of ₹ Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Selling, General, & Admin. Expense for a Medical Devices & Instruments company?
A good Selling, General, & Admin. Expense depends on the Medical Devices & Instruments industry context. However, Selling, General, & Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Selling, General, & Admin. Expense mean?
A high Selling, General, & Admin. Expense can signal that a stock is expensive relative to its fundamentals. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on Bio Medica Laboratories and its competitors. Bio Medica Laboratories's current Selling, General, & Admin. Expense is ₹ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio Medica Laboratories stock overvalued right now?
Bio Medica Laboratories (NSE:BMLL) has a current Selling, General, & Admin. Expense of ₹ Mil. The current Selling, General, & Admin. Expense is ₹ Mil. Bio Medica Laboratories' overall GF Score™ is 18/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Selling, General, & Admin. Expense calculated?
Selling, General, & Admin. Expense is calculated from a company's financial statements. For Bio Medica Laboratories (NSE:BMLL), the current Selling, General, & Admin. Expense is ₹ Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Bio Medica Laboratories Ltd is engaged in the manufacturing of Pharmaceutical Parenteral Formulations. It manufactures generic drugs in the form of injectables namely Liquid Injections and Dry Powder Injections. These injectables are available in both single dose and multi dose forms, catering both human and veterinary needs. Its products address a wide range of medical needs and preferences. The majority of revenue is derived from the sales of Liquid injections. Geographically, it operates predominantly in India, and internationally, it exports to Afghanistan.
18GF Score
Get the complete analysis for NSE:BMLL
Selling, General, & Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:BMLL has been successfully added to your 
